Western Enterprises/Scott Fetzer Company
Letter data
- Company
- Western Enterprises/Scott Fetzer Company
- Recipient
- Andrew Cheshire | President | Western Enterprises/Scott Fetzer Company | Western Enterprises/Scott Fetzer Company | 875 Bussett Road | Westlake | , | OH | 44145 | United States | ACheshire@westernenterprises.com
- Issue date
- 2018-10-09
- Posted date
- Not available
- FDA office
- Center for Devices and Radiological Health
- Subject
- Not available
- Product
- Not available
- CMS ID
- 441366
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Western Enterprises/Scott Fetzer Company
MARCS-CMS 441366 —
October 09, 2018
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Recipient:
Recipient Name
Andrew Cheshire
Recipient Title
President
Western Enterprises/Scott Fetzer Company
Western Enterprises/Scott Fetzer Company
875 Bussett Road
Westlake
,
OH
44145
United States
ACheshire@westernenterprises.com
Issuing Office:
Center for Devices and Radiological Health
6751 Steger Drive
Cincinnati
,
OH
45237-3097
United States
(513) 679-2700
Dear Mr. Cheshire:
The Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our Warning Letter CIN 15-441366-03, dated October 10, 2014. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Gina M. Brackett
Director Compliance Branch
Office of Medical Device and Radiological Health Operations Division 1/East
Cc: Chad Gerbick, Director, Quality and Regulatory CGerbick@WesternEnterprises.com
Content current as of:
10/10/2018